Please login to the form below

MNK-795

This page shows the latest MNK-795 news and features for those working in and with pharma, biotech and healthcare.

Mallinckrodt offers $1.3bn for Cadence Pharma

company.". Mallinckrodt is also active in the analgesia sector and last year won priority review status from the FDA for MNK-795, a controlled-release oral formulation of oxycodone and acetaminophen

Latest news

FDA grants priority review to pain drug

Mallinckrodt’s MNK-795 is intended for the management of moderate to severe acute pain. ... Mallinckrodt has won priority review from the US Food and Drug Administration (FDA) for its pain drug MNK-795.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director, Medical Education: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Digital Account Director: Salary TBC

Project Manager/ Account Manager: Salary TBC

Senior Medical Writer: Great salary and benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Senior Medical Writer: Up to £50, 000 with Benefits

Senior Medical Writer: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The importance of co-creation with patients: Overcoming the barriers...
Three billboards on the road to multichannel: Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence: Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....